• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APPLIED MEDICAL RESOURCES C2A12, GELPOINT V-PATH PLATFORM, 9.5CM; CULDOSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APPLIED MEDICAL RESOURCES C2A12, GELPOINT V-PATH PLATFORM, 9.5CM; CULDOSCOPE (AND ACCESSORIES) Back to Search Results
Model Number C2A12
Device Problem Entrapment of Device (1212)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Procedure performed: hysterectomy bso.Event description: complaint created based off feedback# (b)(4).Case (b)(6) 2024.In order to create the anterior colpotomy, the surgeon inverted the uterus.Once out of position, the uterus remained inverted and was posterior to the alexis (between the alexis and posterior peritoneum) upon insertion.They attempted to insert the alexis twice and noted the entrapped uterine tissue upon visual inspection on both attempts (after rolling down the outer ring, attaching the gelseal cap, and inserting their lap scope/instruments).They did complete a finger sweep prior to rolling alexis outer ring on both attempts, but the entrapped tissue was noted on visual inspection.After the two insertion attempts, they converted to complete a vaginal hyst using voyant.After removing the uterus, the alexis was reinserted successfully to do a vnotes bso.After the case, the surgeon agreed to not invert the uterus in the future.No adverse outcomes were reported.Summary: inverted uterine tissue entrapment, difficulty inserting alexis due to difficult patient anatomy (inverted uterus), conversion to tvh due to patient anatomy, successful vnotes post-hyst intervention: after the two insertion attempts, they converted to complete a vaginal hyst using voyant.After removing the uterus, the alexis was reinserted successfully to do a vnotes bso.Patient status: no adverse outcomes were reported.
 
Manufacturer Narrative
No product is being returned for evaluation and no lot number has been provided to applied medical.A follow-up report will be provided upon completion of investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
C2A12, GELPOINT V-PATH PLATFORM, 9.5CM
Type of Device
CULDOSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
APPLIED MEDICAL RESOURCES
22872 avenida empresa
rancho santa margarita CA 92688
Manufacturer Contact
farah azmi
22872 avenida empresa
rancho santa margarita, CA 92688
9497138710
MDR Report Key18813289
MDR Text Key337633288
Report Number2027111-2024-00424
Device Sequence Number1
Product Code HEW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K191294
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/29/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberC2A12
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/30/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
VOYANT.
-
-